Matches in SemOpenAlex for { <https://semopenalex.org/work/W3212494278> ?p ?o ?g. }
- W3212494278 endingPage "11" @default.
- W3212494278 startingPage "1" @default.
- W3212494278 abstract "Elevated triglycerides (TG) and low high-density lipoprotein cholesterol (HDL-C) define a specific lipid profile associated with residual coronary artery disease (CAD) risk independently of total cholesterol and low-density lipoprotein cholesterol (LDL-C) levels. Aim of the present study was to assess whether TG/HDL-C ratio, coronary atherosclerosis and their change over time are characterized by a specific lipidomic profiling in stable patients with chronic coronary syndrome (CCS).TG/HDL-C ratio was calculated in 193 patients (57.8 ± 7.6 years, 115 males) with CCS characterized by clinical, bio-humoral profiles and cardiac imaging. Patient-specific plasma targeted lipidomics was defined through a high performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) strategy. Patients underwent coronary computed tomography angiography (CTA) and an individual CTA risk score, combining extent, severity, composition, and location of plaques, was calculated. All patients entered a follow-up (6.39 ± 1.17 years), including clinical, lipidomics and coronary CTA assessments.Patients were divided in groups according to baseline TG/HDL-C quartiles: IQ (<1.391), IIQ (1.392-2.000), IIIQ (2.001-3.286), and IVQ (≥3.287). A specific pattern of altered lipids, characterized by reduced plasma levels of cholesterol esters, phosphatidylcholines and sphingomyelins, was associated with higher TG/HDL-C both at baseline and follow-up (IVQ vs IQ). The CTA risk score increased over time and this lipid signature was also associated with higher CTA score at follow-up.In stable CCS, a specific lipidomic signature identifies those patients with higher TG/HDL- C ratio and higher CTA score over time, suggesting possible molecular pathways of residual CAD risk not tackled by current optimal medical treatments." @default.
- W3212494278 created "2021-11-22" @default.
- W3212494278 creator A5001198456 @default.
- W3212494278 creator A5007329233 @default.
- W3212494278 creator A5014507131 @default.
- W3212494278 creator A5027683131 @default.
- W3212494278 creator A5042723074 @default.
- W3212494278 creator A5046456918 @default.
- W3212494278 creator A5046756381 @default.
- W3212494278 creator A5048196647 @default.
- W3212494278 creator A5052938278 @default.
- W3212494278 creator A5057116470 @default.
- W3212494278 creator A5061163769 @default.
- W3212494278 creator A5062181012 @default.
- W3212494278 creator A5067763637 @default.
- W3212494278 creator A5070124449 @default.
- W3212494278 creator A5075598316 @default.
- W3212494278 creator A5081197031 @default.
- W3212494278 date "2021-12-01" @default.
- W3212494278 modified "2023-10-09" @default.
- W3212494278 title "A specific plasma lipid signature associated with high triglycerides and low HDL cholesterol identifies residual CAD risk in patients with chronic coronary syndrome" @default.
- W3212494278 cites W1646734294 @default.
- W3212494278 cites W1797739168 @default.
- W3212494278 cites W1968112386 @default.
- W3212494278 cites W1981002254 @default.
- W3212494278 cites W1988572392 @default.
- W3212494278 cites W1993881492 @default.
- W3212494278 cites W1996344483 @default.
- W3212494278 cites W2002219227 @default.
- W3212494278 cites W2019217568 @default.
- W3212494278 cites W2024545916 @default.
- W3212494278 cites W2035576567 @default.
- W3212494278 cites W2035598079 @default.
- W3212494278 cites W2043154979 @default.
- W3212494278 cites W2053088392 @default.
- W3212494278 cites W2071114782 @default.
- W3212494278 cites W2090023886 @default.
- W3212494278 cites W2096119329 @default.
- W3212494278 cites W2117911718 @default.
- W3212494278 cites W2119634418 @default.
- W3212494278 cites W2120867943 @default.
- W3212494278 cites W2134343469 @default.
- W3212494278 cites W2168526937 @default.
- W3212494278 cites W2170767542 @default.
- W3212494278 cites W2181217557 @default.
- W3212494278 cites W2186319342 @default.
- W3212494278 cites W2270344555 @default.
- W3212494278 cites W2518912440 @default.
- W3212494278 cites W2800837266 @default.
- W3212494278 cites W2909353903 @default.
- W3212494278 cites W2955439866 @default.
- W3212494278 cites W2963867116 @default.
- W3212494278 cites W3011371150 @default.
- W3212494278 cites W3031004561 @default.
- W3212494278 cites W3039971027 @default.
- W3212494278 cites W3045495174 @default.
- W3212494278 cites W3134632592 @default.
- W3212494278 cites W3135466053 @default.
- W3212494278 cites W3206814972 @default.
- W3212494278 doi "https://doi.org/10.1016/j.atherosclerosis.2021.11.013" @default.
- W3212494278 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34801858" @default.
- W3212494278 hasPublicationYear "2021" @default.
- W3212494278 type Work @default.
- W3212494278 sameAs 3212494278 @default.
- W3212494278 citedByCount "4" @default.
- W3212494278 countsByYear W32124942782022 @default.
- W3212494278 countsByYear W32124942782023 @default.
- W3212494278 crossrefType "journal-article" @default.
- W3212494278 hasAuthorship W3212494278A5001198456 @default.
- W3212494278 hasAuthorship W3212494278A5007329233 @default.
- W3212494278 hasAuthorship W3212494278A5014507131 @default.
- W3212494278 hasAuthorship W3212494278A5027683131 @default.
- W3212494278 hasAuthorship W3212494278A5042723074 @default.
- W3212494278 hasAuthorship W3212494278A5046456918 @default.
- W3212494278 hasAuthorship W3212494278A5046756381 @default.
- W3212494278 hasAuthorship W3212494278A5048196647 @default.
- W3212494278 hasAuthorship W3212494278A5052938278 @default.
- W3212494278 hasAuthorship W3212494278A5057116470 @default.
- W3212494278 hasAuthorship W3212494278A5061163769 @default.
- W3212494278 hasAuthorship W3212494278A5062181012 @default.
- W3212494278 hasAuthorship W3212494278A5067763637 @default.
- W3212494278 hasAuthorship W3212494278A5070124449 @default.
- W3212494278 hasAuthorship W3212494278A5075598316 @default.
- W3212494278 hasAuthorship W3212494278A5081197031 @default.
- W3212494278 hasConcept C126322002 @default.
- W3212494278 hasConcept C164705383 @default.
- W3212494278 hasConcept C2778163477 @default.
- W3212494278 hasConcept C2778213512 @default.
- W3212494278 hasConcept C2780541478 @default.
- W3212494278 hasConcept C2991716557 @default.
- W3212494278 hasConcept C58017582 @default.
- W3212494278 hasConcept C60644358 @default.
- W3212494278 hasConcept C61322309 @default.
- W3212494278 hasConcept C71924100 @default.
- W3212494278 hasConcept C86803240 @default.
- W3212494278 hasConceptScore W3212494278C126322002 @default.
- W3212494278 hasConceptScore W3212494278C164705383 @default.
- W3212494278 hasConceptScore W3212494278C2778163477 @default.